CIT Antikörper (C-Term) (HRP)
Kurzübersicht für CIT Antikörper (C-Term) (HRP) (ABIN1973549)
Target
Alle CIT Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Aufreinigung
- Protein G purified
-
Immunogen
-
KLH conjugated synthetic peptide selected from the C-terminal region of human CIT.
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: ELISA, IHC
Usage: The applications listed have been tested for the base form of this product. Alternate forms, such as conjugated, azide-free, or ready-to-use, have not been tested. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.2. No preservative added (azide free)
-
Konservierungsmittel
- Azide free
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
-
Haltbarkeit
- 6 months
-
-
- CIT (Citron (Rho-Interacting, serine/threonine Kinase 21) (CIT))
-
Andere Bezeichnung
- CIT / CRIK / Citron
-
Hintergrund
-
Name/Gene ID: CIT
Subfamily: DMPK
Family: Protein Kinase
Synonyms: CIT, Citron, Citron Rho-interacting kinase, Citron-k kinase, KIAA0949, STK21, CRIK -
Gen-ID
- 11113
-
Pathways
- SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
Target
-